Phase 3 Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able and willing to sign a written consent form
- People who have been diagnosed with type 2 diabetes for at least 90 days
- People who have been on a stable, once-daily dose of basal insulin (with or without metformin and/or an SGLT2 inhibitor medication) for at least 90 days
- People whose HbA1c blood sugar control measure is between 7.5% and 11.0% at the time of screening
- People with a Body Mass Index (BMI) of 22 or higher at the time of screening
Who may not be able to join:
- People with a history of type 1 diabetes, or other specific or secondary forms of diabetes
- People who have had a severe low blood sugar episode in the 180 days before screening
- People who have had a serious heart or stroke-related event in the 180 days before screening
- People who have had a cancer diagnosis within the past 5 years
- People with a known or suspected allergy or sensitivity to the trial medication or related products
- People who have taken part in another clinical trial within the last 90 days
- People whom the trial doctor determines may not be suitable to participate for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-0518-82342973
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in HbA1c
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.